This effect may have therapeutical relevance given that the schistosome, as the taenia and the echinococcus (other praziquantel sensitive parasites), is unable to synthesize purines such as adenosine "de novo".
The combination of the two groups would enable accelerated investment in therapeutical and technological innovation and in the development of more integrated healthcare pathways for patients.
In the therapeutical setting a simple interpretation of the patient's claims is usually leading to a conterproductive debate about who is more correct, the patient or the analyst.
